Cover Image

Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Efe Eworuke, Mayura U. Shinde, Laura Hou, J. Michael Paterson, Peter Bjødstrup Jensen, Judith C. Maro, Ashish Rai, Anton Pottegård, Daniel Scarnecchia, Yuanling Liang, Deborah Johnson, Robert W. Platt, Hana Lee, Marie C. Bradley
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Pharmacoepidemiology and Drug Safety
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

EpiCore —A Common Data Model for Pharmacoepidemiological Studies in Denmark, Norway, and Sweden
by: Peter Bjødstrup Jensen, et al.
Published: (2025)

Transparency, reproducibility, and replicability of pharmacoepidemiology studies in a distributed network environment
by: Ashish Rai, et al.
Published: (2024)

10 Practical Considerations for the Conduct of Multi‐National/Database Studies in Pharmacoepidemiology
by: Kenneth K. C. Man, et al.
Published: (2025)

Advancing Research Transparency and Reproducibility in Pharmacoepidemiology
by: Shirley V. Wang, et al.
Published: (2025)

Preregistration: A Key to Credible Real‐World Evidence Generation
by: Emma Simonsen, et al.
Published: (2025)

Keep Your Guard Up: The Potential Impact of Drug Shortages on Pharmacoepidemiological Studies
by: Araniy Santhireswaran, et al.
Published: (2024)

Time Windows Used When Identifying Current Drug Use and Polypharmacy
by: Sabrina Giometto, et al.
Published: (2026)

High‐Throughput Screening Using the Self‐Controlled Tree‐Based Scan Statistic to Identify Medications Associated With Hospitalization for Severe Acute Liver Injury
by: Vincent Lo Re, et al.
Published: (2025)

Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non‐melanoma Skin Cancer: An Interrupted Time‐Series Analysis Using Swiss Claims Data
by: Tamino Zappalà, et al.
Published: (2024)

Clarithromycin Versus Azithromycin for Community‐Acquired Pneumonia and the Risk of Major Adverse Cardiovascular Events: A Multicentre Cohort Study Using Data From Canada and Denmark
by: Theis Skovsgaard Itenov, et al.
Published: (2025)

The FDA Sentinel Real World Evidence Data Enterprise (RWE‐DE)
by: Rishi J. Desai, et al.
Published: (2024)

The Awareness of and Adherence to the Pregnancy Prevention Program for Oral Retinoids: A Questionnaire Survey in Denmark
by: Dana Backran, et al.
Published: (2024)

Mental Health and Medicine Use for Headache: A Nationally Representative Study of Adolescents in Denmark
by: Bjørn Evald Holstein, et al.
Published: (2024)

Comparing IPCW Models to Adjust for Informative Censoring During COVID ‐19 Using Data From the Clinical Practice Research Datalink
by: Gwen Aubrac, et al.
Published: (2025)

Neonatal Outcome Ascertainment in Mother‐Infant Paired Claims
by: Yehua Wang, et al.
Published: (2026)

Identifying COVID ‐19 Disease Severity in Real‐World Data: Implications for Medical Product Effectiveness Studies
by: Mayura U. Shinde, et al.
Published: (2026)

Empirical Comparison of Exposure Set Definitions in the Prevalent New‐User Design
by: John Tazare, et al.
Published: (2026)

Prescribing trends of proton pump inhibitors and histamine blockers among children in the United Kingdom (1998–2019): A population‐based assessment
by: Reem Masarwa, et al.
Published: (2024)

Validity of Pharmaceutical Claims Data for Determining Medication Exposure in Long‐Term Care Facilities
by: Emma Pearce, et al.
Published: (2024)

Demystifying Clone‐Censor‐Weighting to Study Treatment Initiation Windows: An Example Using Publicly Available Synthetic Medicare Claims Data
by: Michael Webster‐Clark, et al.
Published: (2025)

Capturing Pediatric Health and Medication Use in a US National Health Data Network
by: Ashley I. Michnick, et al.
Published: (2025)

Determining Drug Exposure Based on Medication Dispensing Data: A Validation Study of Vitamin K Antagonist Treatment Episodes Against INR Records
by: Eva K. Kempers, et al.
Published: (2025)

Population‐Based Case–Control Study of Antidepressants in Early and Average‐Age Onset Colorectal Cancer: The Impact of Exposure Window, Class, Dose, and Intensity
by: Vicki Cheng, et al.
Published: (2025)

Perinatal Outcomes After the Use of Kampo Medicines Containing Ephedra During Pregnancy
by: Aoi Noda, et al.
Published: (2025)

A Plasmode Simulation‐Based Bias Analysis for Residual Confounding by Unmeasured Variables Leveraging Information‐Rich Subsets
by: Rishi J. Desai, et al.
Published: (2026)

Overlap Weights for Binary Outcomes: A Performance Assessment
by: Seo Young Park, et al.
Published: (2025)

GP Consultations for Venous Thromboembolism ( VTE ) After mRNA and Adeno‐Vector‐Based COVID ‐19 Vaccination—An Exposure‐Anchored Self‐Controlled Cohort Study Based on Primary Healthcare Data From the Netherlands
by: R. Jajou, et al.
Published: (2026)

Comparing Different As‐Treated Approaches: A Methodological Study Using Real‐World Data on Psoriasis Treatments
by: Sejun Kim, et al.
Published: (2026)

Data Resource Profile: The Danish National Hospital Medicine Register
by: Michael Asger Andersen, et al.
Published: (2024)

Association of Quinolone Exposure in the First‐Trimester of Pregnancy and the Risk of Major Congenital Malformations: A Health Administrative Database Study in Japan
by: Kei Morishita, et al.
Published: (2025)

Risk of Major Congenital Malformations Associated With First‐Trimester Exposure to Topical Antifungal Medications: A Large Claims Database Study
by: Tadaharu Kunitoki, et al.
Published: (2025)

Re‐Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study
by: Maeve E. Wickham, et al.
Published: (2024)

Measuring Exposure to Opioids Using Self‐Reported Medication Use Data Versus General Practitioner Prescription Records in the UK Biobank Study
by: Allison Domingues, et al.
Published: (2025)

Evaluating the Impact of Data Standardization on Real‐World Data
by: Elizabeth M. Garry, et al.
Published: (2025)

Medications Used Among Nonhospitalized Pregnant Women With COVID ‐19: A Prospective Individual Patient Data Meta‐Analysis in Europe and North America
by: Odette de Bruin, et al.
Published: (2025)

Biologics Used for Psoriasis: A Drug Utilization Study Based on Two Nationwide Danish Data Sources
by: Nanna Philbert Engel‐Andreasen, et al.
Published: (2024)

Characterization of SARS‐CoV‐2 Diagnostic Tests and Liver Function Tests Among Patients With COVID‐19 Diagnosed in Outpatient Settings Using Administrative Healthcare Data and Data From Commercial Laboratories
by: Ayad K. Ali, et al.
Published: (2025)

Comment on “Association of Quinolone Exposure in the First Trimester of Pregnancy and the Risk of Major Congenital Malformations: A Health Administrative Database Study in Japan” by Morishita K. Et Al.
by: Mesut Gungor, et al.
Published: (2025)

Oral Anticoagulant Use Among Older Adults in Long‐Term Care Facilities: Trends Over Time and Impact of High‐Risk Comorbidities
by: S. L. Harrison, et al.
Published: (2026)

A Comparative Real‐World Study Evaluating the Safety of Immune Globulin Infusion (Human) 10% Solution and Other Intravenous Immunoglobulin Therapies for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy
by: J. Bradley Layton, et al.
Published: (2025)